0001209191-20-001103.txt : 20200103
0001209191-20-001103.hdr.sgml : 20200103
20200103164727
ACCESSION NUMBER: 0001209191-20-001103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191231
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davidson Michael
CENTRAL INDEX KEY: 0001691467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36517
FILM NUMBER: 20506305
MAIL ADDRESS:
STREET 1: C/O MINERVA NEUROSCIENCES, INC.
STREET 2: 1601 TRAPELO ROAD, SUITE 286
CITY: WLTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Minerva Neurosciences, Inc.
CENTRAL INDEX KEY: 0001598646
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260784194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 286
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-600-7373
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 286
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-31
0
0001598646
Minerva Neurosciences, Inc.
NERV
0001691467
Davidson Michael
C/O MINERVA NEUROSCIENCES, INC.
1601 TRAPELO ROAD, SUITE 286
WALTHAM
MA
02451
0
1
0
0
Chief Medical Officer
Employee Stock Option (right to buy)
7.11
2019-12-31
4
A
0
37216
0.00
A
2029-12-30
Common Stock
37216
37216
D
This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter.
/s/ Ryan Sansom, Attorney-in-Fact
2020-01-03